GSA Capital Partners’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-837
| Closed | -$14K | – | 1753 |
|
|
2024
Q3 | $14K | Buy |
+837
| New | +$14K | ﹤0.01% | 1535 |
|
|
2024
Q2 | – | Sell |
-183
| Closed | -$55K | – | 1782 |
|
|
2024
Q1 | $55K | Sell |
183
-1,827
| -91% | -$549K | ﹤0.01% | 1529 |
|
|
2023
Q4 | $474K | Buy |
2,010
+1,072
| +114% | +$253K | 0.04% | 830 |
|
|
2023
Q3 | $141K | Buy |
+938
| New | +$141K | 0.01% | 1352 |
|
|
2022
Q1 | – | Sell |
-1,461
| Closed | -$210K | – | 1555 |
|
|
2021
Q4 | $210K | Buy |
+1,461
| New | +$210K | 0.03% | 1185 |
|
|
2020
Q2 | – | Sell |
-238
| Closed | -$54K | – | 798 |
|
|
2020
Q1 | $54K | Buy |
238
+84
| +55% | +$19.1K | 0.01% | 955 |
|
|
2019
Q4 | $82K | Buy |
+154
| New | +$82K | 0.01% | 1351 |
|
|
2019
Q3 | – | Sell |
-155
| Closed | -$185K | – | 1501 |
|
|
2019
Q2 | $185K | Buy |
+155
| New | +$185K | 0.02% | 1260 |
|
|
2019
Q1 | – | Sell |
-215
| Closed | -$204K | – | 1522 |
|
|
2018
Q4 | $204K | Buy |
+215
| New | +$204K | 0.02% | 1096 |
|
|
2018
Q1 | – | Sell |
-867
| Closed | -$1.46M | – | 1682 |
|
|
2017
Q4 | $1.46M | Buy |
+867
| New | +$1.46M | 0.09% | 374 |
|